Loading clinical trials...
Loading clinical trials...
A Phase II Study of Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer
Conditions
Interventions
Erlotinib
Thoracic radiotherapy
Locations
1
China
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Start Date
January 1, 2010
Primary Completion Date
December 1, 2010
Completion Date
March 1, 2013
Last Updated
May 17, 2010
NCT06305754
NCT07190248
NCT07100080
NCT07195695
NCT06357533
NCT06731413
Lead Sponsor
Zhejiang Cancer Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions